A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...

HBM Alpha Therapeutics has signed a collaboration and licensing agreement, granting an unnamed business partner exclusive ...

Enveda, a Colorado-based biotech, has received a $20 million investment from French pharma major Sanofi. According to Enveda, ...

UCB (EBR: UCB) exceeded market expectations in the fourth quarter of 2024, reporting revenue of 1.89 billion euros ($2.05 ...

The 3rd Bioequivalence Conference, co-hosted by the International Generic and Biosimilar Medicines Association (IGBA) and ...

French immunotherapy company OSE Immunotherapeutics presented full efficacy and safety data from the induction period of the ...

French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...

US pharma major Eli Lilly plans to bolster its domestic medicine production across therapeutic areas by building four new ...

The US Food and Drug Administration (FDA) has accepted for review Regeneron Pharmaceuticals’ resubmission of the Biologics ...

Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a royalty financing agreement with Castle Creek Biosciences, providing ...

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s ...

Danish dermatology specialist LEO Pharma has announced results showing a strong performance in 2024, with both sales growth ...